Lucilla Parnetti

29.6k total citations · 4 hit papers
350 papers, 14.0k citations indexed

About

Lucilla Parnetti is a scholar working on Physiology, Neurology and Psychiatry and Mental health. According to data from OpenAlex, Lucilla Parnetti has authored 350 papers receiving a total of 14.0k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Physiology, 125 papers in Neurology and 109 papers in Psychiatry and Mental health. Recurrent topics in Lucilla Parnetti's work include Alzheimer's disease research and treatments (111 papers), Parkinson's Disease Mechanisms and Treatments (89 papers) and Dementia and Cognitive Impairment Research (86 papers). Lucilla Parnetti is often cited by papers focused on Alzheimer's disease research and treatments (111 papers), Parkinson's Disease Mechanisms and Treatments (89 papers) and Dementia and Cognitive Impairment Research (86 papers). Lucilla Parnetti collaborates with scholars based in Italy, Sweden and Germany. Lucilla Parnetti's co-authors include Paolo Calabresi, Paolo Eusebi, Kaj Blennow, Lorenzo Gaetani, Massimiliano Di Filippo, Davide Chiasserini, Henrik Zetterberg, Virgilio Gallai, Silvia Paciotti and Umberto Senin and has published in prestigious journals such as Nature Communications, PLoS ONE and Brain.

In The Last Decade

Lucilla Parnetti

336 papers receiving 13.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Mental Deterioration Battery: Normative Data, Diagnostic Reliability and Qualitative Analyses of Cognitive Impairment

1996 1.1k citations Giovanni Augusto Carlesimo, Carlo Caltagirone et al. profile →
Neurofilament light chain as a biomarker in neurological disorders

2019 811 citations Lorenzo Gaetani, Kaj Blennow et al. Journal of Neurology Neurosurgery & Psychiatry profile →
CSF and blood biomarkers for Parkinson's disease

2019 439 citations Lucilla Parnetti, Lorenzo Gaetani et al. profile →
Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay

2024 44 citations Giovanni Bellomo, Federico Paolini Paoletti et al. profile →

Peers

Countries citing papers authored by Lucilla Parnetti

Since Specialization

Citations

This map shows the geographic impact of Lucilla Parnetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucilla Parnetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucilla Parnetti more than expected).

Fields of papers citing papers by Lucilla Parnetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucilla Parnetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucilla Parnetti. The network helps show where Lucilla Parnetti may publish in the future.

Co-authorship network of co-authors of Lucilla Parnetti

This figure shows the co-authorship network connecting the top 25 collaborators of Lucilla Parnetti. A scholar is included among the top collaborators of Lucilla Parnetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucilla Parnetti. Lucilla Parnetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective 2025 ·Journal of Neurology ·(unknown), Diana Ferraro, Lorenzo Gaetani, (unknown), Lucilla Parnetti, Massimiliano Di Filippo	0
2	Serum level changes of the synaptic marker beta-synuclein in Alzheimer’s disease continuum and other dementias 2025 ·Journal of Neurology Neurosurgery & Psychiatry ·Lorenzo Barba, Giovanni Bellomo, Daniel Alcolea, (unknown), Lorenzo Gaetani, Juan Fortea, Samir Abu‐Rumeileh, Alberto Lleó, Lucilla Parnetti, Olivia Belbin, Markus Otto, Patrick Oeckl	0
3	Hyposmia correlates with axial signs and gait disorder in Parkinson’s disease: an Italian Olfactory Identification Test study 2024 ·Neurological Sciences ·Nicola Tambasco, Alessandro Mechelli, Pasquale Nigro, Simone Simoni, Federico Paolini Paoletti, Paolo Eusebi, (unknown), Carlo Maremmani, Lucilla Parnetti	0
4	LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes 2023 ·Movement Disorders ·Andrea Mancini, Erik Stoops, (unknown), Giovanni Bellomo, Federico Paolini Paoletti, Lorenzo Gaetani, Massimiliano Di Filippo, Lucilla Parnetti	3
5	Redefinition of dementia care in Italy in the era of amyloid-lowering agents for the treatment of Alzheimer’s disease: an expert opinion and practical guideline 2023 ·Journal of Neurology ·Massimo Filippi, Giordano Cecchetti, (unknown), Camillo Marra, Flavio Nobili, Lucilla Parnetti, Federica Agosta	4
6	CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 2023 ·Neurology ·Lorenzo Barba, Samir Abu‐Rumeileh, Steffen Halbgebauer, Giovanni Bellomo, Federico Paolini Paoletti, Lorenzo Gaetani, Patrick Oeckl, Petra Steinacker, Federico Massa, Lucilla Parnetti, Markus Otto	24
7	CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa^® assays targeting distinct amyloid regions 2023 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), Giovanni Bellomo, (unknown), Lorenzo Gaetani, Lucilla Parnetti, Davide Chiasserini	8
8	A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias 2022 ·Journal of Alzheimer s Disease ·(unknown), (unknown), (unknown), (unknown), Dirk Jacobs, Giovanni Bellomo, Federico Paolini Paoletti, Eugeen Vanmechelen, Charlotte E. Teunissen, Lucilla Parnetti, Eline A.J. Willemse	22
9	An Updated Overview of the Magnetic Resonance Imaging of Brain Iron in Movement Disorders 2022 ·Behavioural Neurology ·Nicola Tambasco, Pasquale Nigro, (unknown), Federico Paolini Paoletti, (unknown), Simone Simoni, P Chiarini, Lucilla Parnetti	6
10	Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer’s Disease 2022 ·International Journal of Molecular Sciences ·Lorenzo Barba, Steffen Halbgebauer, Federico Paolini Paoletti, Giovanni Bellomo, Samir Abu‐Rumeileh, Petra Steinacker, Federico Massa, Lucilla Parnetti, Markus Otto	7
11	High performance liquid chromatography determination of l-glutamate, l-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer’s disease 2021 ·Amino Acids ·Tommaso Nuzzo, Andrea Mancini, Mattia Miroballo, (unknown), Anna Maio, (unknown), (unknown), Lorenzo Gaetani, Federico Paolini Paoletti, Andrea M. Isidori, Paolo Calabresi, Francesco Errico, Lucilla Parnetti, Alessandro Usiello	28
12	Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis 2021 ·International Journal of Molecular Sciences ·Giulia Menculini, Elena Chipi, Federico Paolini Paoletti, Lorenzo Gaetani, Pasquale Nigro, Simone Simoni, Andrea Mancini, Nicola Tambasco, Massimiliano Di Filippo, Alfonso Tortorella, Lucilla Parnetti	22
13	Fingerprinting Alzheimer’s Disease by ¹H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid 2020 ·Journal of Proteome Research ·Alessia Vignoli, Silvia Paciotti, Leonardo Tenori, Paolo Eusebi, Leonardo Biscetti, Davide Chiasserini, Philip Scheltens, Paola Turano, Charlotte E. Teunissen, Claudio Luchinat, Lucilla Parnetti	33
14	T2-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 2019 ·Neurobiology of Aging* ·Nicola Tambasco, Federico Paolini Paoletti, (unknown), Viviana Lisetti, Pasquale Nigro, Paolo Eusebi, P Chiarini, Michele Romoli, (unknown), Simone Simoni, (unknown), Piero Floridi, R. Tarducci, Lucilla Parnetti, Paolo Calabresi	19
15	FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort 2018 ·NeuroImage Clinical ·Silvia Paola Caminiti, Tommaso Ballarini, Arianna Sala, Chiara Cerami, Luca Presotto, Roberto Santangelo, Federico Fallanca, Emilia Giovanna Vanoli, Luigi Gianolli, Sandro Iannaccone, Giuseppe Magnani, Daniela Perani, Lucilla Parnetti, Paolo Eusebi, Giovanni B. Frisoni, Flavio Nobili, Agnese Picco, Elio Scarpini	101
16	Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis 2016 ·BMJ Open ·Paolo Eusebi, David Giannandrea, Leonardo Biscetti, Iosief Abraha, Davide Chiasserini, Massimiliano Orso, Paolo Calabresi, Lucilla Parnetti	12
17	Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy 2008 ·Neurology ·Barbara Borroni, Matteo Malinverno, Fabrizio Gardoni, Antonella Alberici, Lucilla Parnetti, Enrico Premi, Ubaldo Bonuccelli, Mario Grassi, Daniela Perani, Paolo Calabresi, Mónica Di Luca, Alessandro Padovani	69
18	Analytical performance and clinical utility of the INNOTEST® PHOSPHO-TAU(181P) assay for discrimination between Alzheimer's disease and dementia with Lewy bodies 2006 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Hugo Vanderstichele, K De Vreese, Kaj Blennow, Niels Andreasen, Christian Sindic, Adrian Ivanoiu, Harald Hampel, Katharina Bürger, Lucilla Parnetti, Alessia Lanari, Alessandro Padovani, Mónica Di Luca, (unknown), Annika Olsson, Hans Pottel, Frank Hulstaert, Eugeen Vanmechelen	131
19	Vascular Dementia: The Role of Cerebral Infarcts 1999 ·Alzheimer Disease & Associated Disorders ·Didier Leys, Timo Erkinjuntti, David W. Desmond, Reinhold Schmidt, Elisabet Englund, Florence Pasquier, Lucilla Parnetti, Joseph Ghika, Rajesh N. Kalaria, Hugues Chabriat, Philip Scheltens, Julien Bogousslavsky	52
20	The Mental Deterioration Battery (Part 1): Description of a instrument of the neuropsychological diagnosis 1995 ·Carlo Caltagirone, Guido Gainotti, Giovanni Augusto Carlesimo, Lucilla Parnetti, Lucia Fadda, R. Gallassi, Sebastiano Lorusso, Girolama Alessandra Marfia, Camillo Marra, Ugo Nocentini	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact